Open AccessSerum Exosomal EphA2 is a Prognostic Biomarker in Patients with Pancreatic Cancer
Author(s) -
Wei Qian,
Ze Li,
Hui Feng,
Li Ren
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s304719
Subject(s) - pancreatic cancer , biomarker , medicine , eph receptor a2 , oncology , cancer , biology , receptor , biochemistry , receptor tyrosine kinase
Pancreatic cancer (PC) is one of the worst prognoses amongst all malignant diseases. It is therefore of great significance to identify biomarkers with predictive clinical value for the prognosis and recurrence of PC.